GIANFALDONI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.554
EU - Europa 1.012
AS - Asia 752
SA - Sud America 111
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 16
OC - Oceania 5
Totale 3.472
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.525
RU - Federazione Russa 315
IT - Italia 251
CN - Cina 223
SG - Singapore 211
PL - Polonia 140
HK - Hong Kong 96
BR - Brasile 88
VN - Vietnam 65
KR - Corea 62
IE - Irlanda 55
SE - Svezia 49
FR - Francia 38
DE - Germania 35
FI - Finlandia 35
GB - Regno Unito 30
CH - Svizzera 28
IN - India 20
JO - Giordania 18
BD - Bangladesh 15
CA - Canada 13
NL - Olanda 8
UA - Ucraina 8
ES - Italia 7
ID - Indonesia 7
JP - Giappone 7
AR - Argentina 6
CO - Colombia 6
IQ - Iraq 6
AU - Australia 5
JM - Giamaica 5
TR - Turchia 5
VE - Venezuela 5
ZA - Sudafrica 5
BE - Belgio 3
LV - Lettonia 3
MX - Messico 3
PK - Pakistan 3
SV - El Salvador 3
CI - Costa d'Avorio 2
CL - Cile 2
HN - Honduras 2
KE - Kenya 2
MA - Marocco 2
NG - Nigeria 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 3.451
Salva come PNG Salva come JPEG
Città #
Santa Clara 362
Ashburn 211
Singapore 161
Warsaw 139
Fairfield 107
Hong Kong 88
San Jose 73
Seoul 62
Chandler 61
Beijing 56
Dublin 55
Hefei 54
Seattle 46
Woodbridge 44
Milan 42
Houston 36
New York 31
Cambridge 30
Wilmington 29
Bern 26
Florence 24
Ho Chi Minh City 24
Los Angeles 24
Rome 24
Altamura 22
Lawrence 22
Buffalo 21
Council Bluffs 21
Ann Arbor 20
Dallas 19
Moscow 19
Munich 19
Paris 18
The Dalles 18
Kent 17
Turku 17
Lauterbourg 15
Princeton 14
Hanoi 11
Medford 11
Phoenix 11
Shanghai 11
Helsinki 9
Mumbai 9
Boston 7
London 7
San Diego 7
Turin 7
Bremen 6
Frankfurt am Main 6
Jakarta 6
San Francisco 6
São Paulo 6
Tokyo 6
Atlanta 5
Brooklyn 5
Denver 5
Manchester 5
Manresa 5
Melbourne 5
Poplar 5
Amsterdam 4
Boardman 4
Bologna 4
Clifton 4
Figino 4
Hillsboro 4
Jacksonville 4
Lappeenranta 4
Miano 4
Montreal 4
Naples 4
Palermo 4
Porto Alegre 4
Siena 4
Baghdad 3
Bari 3
Brasília 3
Brussels 3
Chicago 3
Falls Church 3
Johannesburg 3
Kingston 3
Kolkata 3
Redondo Beach 3
Riga 3
Rio de Janeiro 3
San Salvador 3
St Louis 3
Toronto 3
Yubileyny 3
Abidjan 2
Amman 2
Belo Horizonte 2
Biên Hòa 2
Bolzano 2
Brescia 2
Casablanca 2
Cleveland 2
Colby 2
Totale 2.354
Salva come PNG Salva come JPEG
Nome #
CD20 expression has no prognostic role in Philadelphia-negativeB-precursor acute lymphoblastic leukemia: new insights from the molecularstudy of minimal residual disease. 329
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial 225
Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia 221
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML 209
THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS 205
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 202
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey 200
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia. 198
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in AML 194
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia 192
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia. 190
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. 187
Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience 171
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance – MYNERVA-GIMEMA AML1919 trial 160
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm 158
Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML 151
Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting 121
Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report 114
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia 23
APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications. 22
Totale 3.472
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202288 0 0 9 2 3 6 4 12 3 2 19 28
2022/2023299 22 74 18 14 14 41 29 14 36 2 6 29
2023/2024178 4 9 13 14 21 39 3 35 4 13 16 7
2024/2025985 36 79 52 132 269 164 21 38 35 37 50 72
2025/20261.257 155 156 125 123 132 53 119 46 62 96 39 151
2026/2027116 38 22 56 0 0 0 0 0 0 0 0 0
Totale 3.472